Все публикации

0:04:00

Mirvetuximab soravtansine shows promise in FRα-positive, platinum-sensitive ovarian cancer

0:05:58

Endocrine therapy plus trastuzumab and pertuzumab shows excellent survival outcomes in HR and HE...

0:04:08

Nivolumab plus ipilimumab improves efficacy versus standard of care in non-clear-cell renal cell...

0:02:40

More effective treatment options required for patients with MM post lenalidomide exposure

0:04:47

Melflufen and dexamethasone versus pomalidomide and dexamethasone in relapsed refractory multipl...

0:04:31

Avelumab combined with regorafenib shows improved outcome in solid tumours with tertiary lymphoi...

0:08:58

Conflicts of interest in oncology

0:03:04

Ponatinib is superior to imatinib in combination with chemotherapy for patients with newly diagn...

0:07:32

CAR-T therapy and impact to cancer patient outcomes and experience of treatment

0:07:33

Epitope editing enables targeted immunotherapy of acute myeloid leukaemia

0:02:30

Prognostic value of HER2-low status in breast cancer: A systematic review and meta-analysis

0:05:08

Pregnancy after breast cancer

0:58:50

Advancing breast cancer diagnosis in the developing world

0:06:04

IORT at University Hospital Augsburg in Germany

0:05:26

Trastuzumab deruxtecan shows benefit in patients with HER2 + mBC

0:06:45

Zanubrutinib demonstrates superior PFS compared with ibrutinib for treatment of R/R CLL and SLL

0:07:12

T-DXd demonstrates high levels of efficacy in patients with HER2+ unresectable and/or mBC previo...

0:04:01

Management of HER2 positive metastatic breast cancer treatment algorithm

0:04:37

Spindle cell lesions of the breast

0:01:22

The role of lymph nodes in stage 3 lung cancer

0:03:46

Evidence-based approach to lymph node assessment and targeted axillary dissection

0:06:46

Updates on HER2-low breast cancer

0:03:38

FLASH-radiation therapy: hype or game changer?

0:04:28

Upfront [177Lu]Lu-PSMA-617 radioligand therapy prior to radical prostatectomy in men with HR PC